These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 16482646

  • 21. Comparison of two etanercept regimens for treatment of psoriasis and psoriatic arthritis: PRESTA randomised double blind multicentre trial.
    Sterry W, Ortonne JP, Kirkham B, Brocq O, Robertson D, Pedersen RD, Estojak J, Molta CT, Freundlich B.
    BMJ; 2010 Feb 02; 340():c147. PubMed ID: 20124563
    [Abstract] [Full Text] [Related]

  • 22. Sustained durability and tolerability of etanercept in ankylosing spondylitis for 96 weeks.
    Davis JC, van der Heijde DM, Braun J, Dougados M, Cush J, Clegg D, Inman RD, Kivitz A, Zhou L, Solinger A, Tsuji W.
    Ann Rheum Dis; 2005 Nov 02; 64(11):1557-62. PubMed ID: 15843448
    [Abstract] [Full Text] [Related]

  • 23. Etanercept in combination with sulfasalazine, hydroxychloroquine, or gold in the treatment of rheumatoid arthritis.
    O'Dell JR, Petersen K, Leff R, Palmer W, Schned E, Blakely K, Haire C, Fernandez A.
    J Rheumatol; 2006 Feb 02; 33(2):213-8. PubMed ID: 16358366
    [Abstract] [Full Text] [Related]

  • 24. Comparison of the response to infliximab or etanercept monotherapy with the response to cotherapy with methotrexate or another disease-modifying antirheumatic drug in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
    Hyrich KL, Symmons DP, Watson KD, Silman AJ, British Society for Rheumatology Biologics Register.
    Arthritis Rheum; 2006 Jun 02; 54(6):1786-94. PubMed ID: 16736520
    [Abstract] [Full Text] [Related]

  • 25. Rapid reduction in tenosynovitis of the wrist and fingers evaluated by MRI in patients with rheumatoid arthritis after treatment with etanercept.
    Lisbona MP, Maymó J, Perich J, Almirall M, Carbonell J.
    Ann Rheum Dis; 2010 Jun 02; 69(6):1117-22. PubMed ID: 20448287
    [Abstract] [Full Text] [Related]

  • 26. Etanercept (Enbrel) in patients with rheumatoid arthritis with recent onset versus established disease: improvement in disability.
    Baumgartner SW, Fleischmann RM, Moreland LW, Schiff MH, Markenson J, Whitmore JB.
    J Rheumatol; 2004 Aug 02; 31(8):1532-7. PubMed ID: 15290731
    [Abstract] [Full Text] [Related]

  • 27. Association between etanercept use and employment outcomes among patients with rheumatoid arthritis.
    Yelin E, Trupin L, Katz P, Lubeck D, Rush S, Wanke L.
    Arthritis Rheum; 2003 Nov 02; 48(11):3046-54. PubMed ID: 14613265
    [Abstract] [Full Text] [Related]

  • 28. Selective costimulation modulation using abatacept in patients with active rheumatoid arthritis while receiving etanercept: a randomised clinical trial.
    Weinblatt M, Schiff M, Goldman A, Kremer J, Luggen M, Li T, Chen D, Becker JC.
    Ann Rheum Dis; 2007 Feb 02; 66(2):228-34. PubMed ID: 16935912
    [Abstract] [Full Text] [Related]

  • 29. Etanercept 50 mg once weekly is as effective as 25 mg twice weekly in patients with ankylosing spondylitis.
    van der Heijde D, Da Silva JC, Dougados M, Geher P, van der Horst-Bruinsma I, Juanola X, Olivieri I, Raeman F, Settas L, Sieper J, Szechinski J, Walker D, Boussuge MP, Wajdula JS, Paolozzi L, Fatenejad S, Etanercept Study 314 Investigators.
    Ann Rheum Dis; 2006 Dec 02; 65(12):1572-7. PubMed ID: 16968715
    [Abstract] [Full Text] [Related]

  • 30. Safety and efficacy of once weekly etanercept 0.8 mg/kg in a multicentre 12 week trial in active polyarticular course juvenile idiopathic arthritis.
    Horneff G, Ebert A, Fitter S, Minden K, Foeldvari I, Kümmerle-Deschner J, Thon A, Girschick HJ, Weller F, Huppertz HI.
    Rheumatology (Oxford); 2009 Aug 02; 48(8):916-9. PubMed ID: 19483091
    [Abstract] [Full Text] [Related]

  • 31. Prolonged efficacy of etanercept in refractory enthesitis-related arthritis.
    Henrickson M, Reiff A.
    J Rheumatol; 2004 Oct 02; 31(10):2055-61. PubMed ID: 15468375
    [Abstract] [Full Text] [Related]

  • 32. Clinical data gap between phase III clinical trials (pre-marketing) and phase IV (post-marketing) studies: evaluation of etanercept in rheumatoid arthritis.
    Farahani P, Levine M, Gaebel K, Thabane L.
    Can J Clin Pharmacol; 2005 Oct 02; 12(3):e254-63. PubMed ID: 16278497
    [Abstract] [Full Text] [Related]

  • 33. Efficacy, effectiveness and safety of etanercept in monotherapy for refractory psoriatic arthritis: a 26-week observational study.
    de Vlam K, Lories RJ.
    Rheumatology (Oxford); 2006 Mar 02; 45(3):321-4. PubMed ID: 16234275
    [Abstract] [Full Text] [Related]

  • 34. Etanercept in severe active rheumatoid arthritis: first Australian experience.
    Perera LC, Tymms KE, Wilson BJ, Shadbolt B, Brook AS, Dorai Raj AK, Khoo KB.
    Intern Med J; 2006 Oct 02; 36(10):625-31. PubMed ID: 16958637
    [Abstract] [Full Text] [Related]

  • 35. Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks.
    Cohen SB, Emery P, Greenwald MW, Dougados M, Furie RA, Genovese MC, Keystone EC, Loveless JE, Burmester GR, Cravets MW, Hessey EW, Shaw T, Totoritis MC, REFLEX Trial Group.
    Arthritis Rheum; 2006 Sep 02; 54(9):2793-806. PubMed ID: 16947627
    [Abstract] [Full Text] [Related]

  • 36. Etanercept treatment in adults with established rheumatoid arthritis: 7 years of clinical experience.
    Moreland LW, Weinblatt ME, Keystone EC, Kremer JM, Martin RW, Schiff MH, Whitmore JB, White BW.
    J Rheumatol; 2006 May 02; 33(5):854-61. PubMed ID: 16541481
    [Abstract] [Full Text] [Related]

  • 37. Successful short term treatment of patients with severe undifferentiated spondyloarthritis with the anti-tumor necrosis factor-alpha fusion receptor protein etanercept.
    Brandt J, Khariouzov A, Listing J, Haibel H, Sörensen H, Rudwaleit M, Sieper J, Braun J.
    J Rheumatol; 2004 Mar 02; 31(3):531-8. PubMed ID: 14994401
    [Abstract] [Full Text] [Related]

  • 38. Long-term efficacy and safety of etanercept after readministration in patients with active ankylosing spondylitis.
    Brandt J, Listing J, Haibel H, Sörensen H, Schwebig A, Rudwaleit M, Sieper J, Braun J.
    Rheumatology (Oxford); 2005 Mar 02; 44(3):342-8. PubMed ID: 15561737
    [Abstract] [Full Text] [Related]

  • 39. A phase 2 dose-finding study of PEGylated recombinant methionyl human soluble tumor necrosis factor type I in patients with rheumatoid arthritis.
    Furst DE, Fleischmann R, Kopp E, Schiff M, Edwards C, Solinger A, Macri M, 990136 Study Group.
    J Rheumatol; 2005 Dec 02; 32(12):2303-10. PubMed ID: 16331754
    [Abstract] [Full Text] [Related]

  • 40. Inhibition of radiographic progression with combination etanercept and methotrexate in patients with moderately active rheumatoid arthritis previously treated with monotherapy.
    van der Heijde D, Burmester G, Melo-Gomes J, Codreanu C, Martin Mola E, Pedersen R, Robertson D, Chang D, Koenig A, Freundlich B, Etanercept Study Investigators.
    Ann Rheum Dis; 2009 Jul 02; 68(7):1113-8. PubMed ID: 18718986
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.